Catatonia maligna responsiva a baixas doses de lorazepam: Relato de caso

2Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CONTEXT: Catatonia can be divided into non-malignant or malignant. The latter is characterized by autonomic instability, exhibiting high fever, tachycardia and hypertension, and is regarded as a fulminant and rapidly progressive subtype. CASE REPORT: This article reports a case of malignant catatonia in a 43-year-old patient who had been presenting psychiatric disorders for the last three years. The patient was stable, maintaining mutism, immobility and autonomic abnormalities. Oral lorazepam (1 mg every eight hours) was introduced and, in a few hours, the patient became afebrile. Two days later, the patient was already responding to verbal commands. CONCLUSIONS: Early intervention with lorazepam reduced the evolution of this patient to a fatal complication. Therefore, this case report sought to show that early diagnosis and intervention reduced the occurrence of serious and irreversible clinical outcomes.

Cite

CITATION STYLE

APA

Matias, D. F. M., Ando, S. de M., Riera, R., & de Góis, A. F. T. (2016). Catatonia maligna responsiva a baixas doses de lorazepam: Relato de caso. Sao Paulo Medical Journal, 134(2), 176–179. https://doi.org/10.1590/1516-3180.2014.00052608

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free